The expression of the protein was absent in several pancreatic cancer cell lines and it was downregulated in 9 samples of pancreatic adenocarcinoma compared with 8 samples of normal pancreas, due to increased methylation of the BNIP3 promoter [18]. Here, BNIP3 is linked to pancreatic neoplasm.